ESTRADOT 25
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of ESTRADOT 25 in Canada?
A shortage of ESTRADOT 25 25MCG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 13, 2026), but it has not started yet.
Why is ESTRADOT 25 not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will ESTRADOT 25 be available again?
The manufacturer's estimated resolution date is November 20, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Menopause Hormone Therapy (HRT) Shortage in Canada: Estrogen Patches, Pills & Creams
Which menopausal hormone therapy products — Premarin, Estrace, Estradot, Climara, Estalis, Duavive — have had shortage reports in Canada in 2026, why HRT shortages keep recurring, and what to ask your pharmacist.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ESTRING
PFIZER CANADA ULC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-11-20
~33 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02245676
Strength
25MCG
Dosage Form
PATCH
Route
TRANSDERMAL
Active Ingredient
ESTRADIOL
Tier
Unrated
Last Updated
2026-10-13
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
ESTRADOT 25 has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759